U.S. flag

An official website of the United States government

NM_000179.3(MSH6):c.4004A>C (p.Glu1335Ala) AND not specified

Germline classification:
Likely benign (1 submission)
Last evaluated:
Mar 26, 2024
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001375525.5

Allele description [Variation Report for NM_000179.3(MSH6):c.4004A>C (p.Glu1335Ala)]

NM_000179.3(MSH6):c.4004A>C (p.Glu1335Ala)

Gene:
MSH6:mutS homolog 6 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2p16.3
Genomic location:
Preferred name:
NM_000179.3(MSH6):c.4004A>C (p.Glu1335Ala)
HGVS:
  • NC_000002.12:g.47806781A>C
  • NG_007111.1:g.28635A>C
  • NG_008397.1:g.103895T>G
  • NM_000179.3:c.4004A>CMANE SELECT
  • NM_001281492.2:c.3614A>C
  • NM_001281493.2:c.3098A>C
  • NM_001281494.2:c.3098A>C
  • NP_000170.1:p.Glu1335Ala
  • NP_000170.1:p.Glu1335Ala
  • NP_001268421.1:p.Glu1205Ala
  • NP_001268422.1:p.Glu1033Ala
  • NP_001268423.1:p.Glu1033Ala
  • LRG_219t1:c.4004A>C
  • LRG_219:g.28635A>C
  • LRG_219p1:p.Glu1335Ala
  • NC_000002.11:g.48033920A>C
  • NM_000179.2:c.4004A>C
  • p.E1335A
Protein change:
E1033A
Links:
dbSNP: rs564434147
NCBI 1000 Genomes Browser:
rs564434147
Molecular consequence:
  • NM_000179.3:c.4004A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281492.2:c.3614A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281493.2:c.3098A>C - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001281494.2:c.3098A>C - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
AllHighlyPenetrant
Identifiers:
MedGen: CN169374

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001572381Women's Health and Genetics/Laboratory Corporation of America, LabCorp
criteria provided, single submitter

(LabCorp Variant Classification Summary - May 2015)
Likely benign
(Mar 26, 2024)
germlineclinical testing

PubMed (6)
[See all records that cite these PMIDs]

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Citations

PubMed

Evaluating the effect of unclassified variants identified in MMR genes using phenotypic features, bioinformatics prediction, and RNA assays.

Pérez-Cabornero L, Infante M, Velasco E, Lastra E, Miner C, Durán M.

J Mol Diagn. 2013 May;15(3):380-90. doi: 10.1016/j.jmoldx.2013.02.003. Epub 2013 Mar 20.

PubMed [citation]
PMID:
23523604

Integrated analysis of mismatch repair system in malignant astrocytomas.

Rodríguez-Hernández I, Garcia JL, Santos-Briz A, Hernández-Laín A, González-Valero JM, Gómez-Moreta JA, Toldos-González O, Cruz JJ, Martin-Vallejo J, González-Sarmiento R.

PLoS One. 2013;8(9):e76401. doi: 10.1371/journal.pone.0076401.

PubMed [citation]
PMID:
24073290
PMCID:
PMC3779191
See all PubMed Citations (6)

Details of each submission

From Women's Health and Genetics/Laboratory Corporation of America, LabCorp, SCV001572381.5

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (6)

Description

Variant summary: MSH6 c.4004A>C (p.Glu1335Ala) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. Consensus agreement among computation tools predict no significant impact on normal splicing. However, these predictions have yet to be confirmed by functional studies. The variant allele was found at a frequency of 5.2e-05 in 1590584 control chromosomes, predominantly at a frequency of 0.00036 within the South Asian subpopulation in the gnomAD database. The observed variant frequency within South Asian control individuals in the gnomAD database is approximately 2.5 fold of the estimated maximal expected allele frequency for a pathogenic variant in MSH6 causing Lynch syndrome (0.00014), strongly suggesting that the variant is a benign polymorphism found primarily in populations of South Asian origin. c.4004A>C has been reported in the literature in individuals undergoing multigene panel testing for hereditary cancers such as Lynch, low grade astrocytoma and breast (example, Perez-Cabornero_2013, Rodriguez-Hernandez_2013, Cock-Rada_2017, Nikitin_2020). These report(s) do not provide unequivocal conclusions about association of the variant with Lynch Syndrome. At-least three co-occurrences with other pathogenic variant(s) have been reported in the literature and observed at our laboratory (BRCA1 c.5266dupC, p.Gln1756Profs, Nikitin_2020; PALB2 c.1317delG, p.Phe440fs, internal testing; CDH1 c.537delA , p.Lys179Asnfs*36, internal testing), providing supporting evidence for a benign role. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. A study that computed a tumor characteristic likelihood ratio (TCLR) in combination with in-silico predictors and multifactorial variant prediction (MVP) model including allele frequency, co-occurrence, co-segregation, clinical and family history information classified this variant a "likely benign". The following publications have been ascertained in the context of this evaluation (PMID: 30306255, 28528518, 31391288, 32547938, 23523604, 24073290). ClinVar contains an entry for this variant (Variation ID: 141327). Some submitters cite overlapping but not identical evidences utilized in the context of this evaluation. Based on the evidence outlined above, the variant was classified as likely benign.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Nov 10, 2024